REVIA NALTREXONE HCI

USPTO USPTO 1996 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark REVIA NALTREXONE HCI was filed as Word and figurative mark on 10/24/1996 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/09/1998. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: May 5, 2018

Trademark form Word and figurative mark
File reference 75187094
Register number 2163346
Application date October 24, 1996
Publication date March 17, 1998
Entry date June 9, 1998

Trademark owner

DuPont Merck Plaza, 974 Centre Road
198072802 Wilmington
US

Trademark representatives

goods and services

42 providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence

ID: 1375187094